Summary:
1. Greenhaven Associates disclosed a new position in Avantor, acquiring $228.53 million in shares.
2. Avantor now accounts for 4.42% of Greenhaven’s fund AUM, outside its top five holdings.
3. Avantor is a global provider of products and services supporting life sciences, healthcare, and advanced technology industries.
Article:
On November 4, 2025, investment firm Greenhaven Associates revealed a significant move by acquiring a new position in Avantor, totaling approximately $228.53 million in shares. This strategic investment was based on quarterly average prices reported in their Form 13F filing for the period ended September 30, 2025. Greenhaven purchased 18,311,570 Avantor shares, solidifying their stake in the company’s growth potential.
Following this transaction, Avantor now represents 4.42% of Greenhaven’s fund AUM, positioning it outside the top five holdings of the firm. This move indicates Greenhaven’s confidence in Avantor’s future prospects and its potential to deliver strong returns in the long term.
Avantor, a global leader in providing mission-critical products and services to industries such as life sciences, healthcare, and advanced technology, offers a wide range of high-purity chemicals, laboratory consumables, equipment, and specialty services. The company plays a vital role in enabling scientific innovation and operational efficiency for its diverse clientele.
With a focus on generating revenue through the sale of consumables, equipment, and value-added services, Avantor serves a broad spectrum of clients, including biopharmaceutical companies, healthcare providers, academic institutions, and industrial organizations worldwide. Its steady base of recurring revenue and essential products position Avantor as a reliable partner in the scientific supply chain, making it a valuable investment opportunity for stakeholders seeking exposure to the healthcare and technology sectors.
In conclusion, Greenhaven Associates’ strategic investment in Avantor reflects a vote of confidence in the company’s growth potential and market position. As Avantor continues to innovate and expand its offerings in critical industries, investors can expect to see promising returns and opportunities for long-term growth.
